Play all audios:
MUMBAI, India, March 7, 2012 /PRNewswire/ -- SIRO Clinpharm, a leading full service Clinical Research Organization announced the appointment of Gopakumar Menon as Chief Executive Officer.
SIRO has developed a long term plan to align with the changing dynamics of the biopharma industry, and his primary charter is to transform SIRO into a global leader in the CRO and FSP space.
He will be responsible for continuing to build and enhance the biopharma service catalog for SIRO's global delivery model, across the Americas, Europe and Asia. "It is a pleasure
to have Gopakumar on board. Gopakumar brings with him rich experience in driving business growth, and delivering tremendous value for leading companies, including Fortune 1000
companies," said Dr. Gautam Daftary, Chairman of SIRO Clinpharm. "Gopakumar has an excellent track record in cultivating partnership based relationships with Fortune 500
pharmaceutical client base, envisioning cutting-edge business and technical solutions for clients across U.S., Europe, Japan, India, China and Singapore. His experience and knowledge will
help SIRO to enhance its services, and build a strong presence in new markets where the company plans to expand its frontiers." "The biopharma industry is undergoing significant
transformations. Clients are actively seeking quality service providers from the emerging markets, who can understand their specific challenges, and partner to build and deliver innovative
solutions in a global delivery model," said Gopakumar. "My first priority will be to leverage decades of experience, tremendous value, and geographic reach of SIRO to make it the
partner of choice for business critical services of global biopharma leaders. I look forward to working with Gautam and SIRO's board of directors." Gopakumar has been with the
pharmaceutical industry for the more than 12 years, where he worked in various capacities, from discovery to sales and marketing. Prior to joining SIRO Clinpharm, Gopakumar was with Boston
based Sciformix Inc. Gopakumar has had significant experience working with Fortune 500 companies like Cognizant and Satyam, in their Life Sciences divisions, as well as with venture funded
start-up organizations. About SIRO: SIRO Clinpharm, winner of Frost & Sullivan Indian Clinical Research Organization of the year 2011 award, is a drug development solutions provider to
the global healthcare industry. Our subject expertise gives us an edge in data management, medical writing, biostatistics & clinical trial management. Having a successful track record of
16 years, SIRO works with most top global biopharma & medical device companies. Our therapeutic experience includes but is not limited to oncology, diabetes, cardiology, infectious
diseases & respiratory system. We offer flexible business models across service verticals based on client needs. The company has offices in India, Malaysia, USA, and Israel and in Europe
at Germany, Romania, Estonia, Greece, Czech Republic and Spain. For more information please visit our website- http://www.siroclinpharm.com Media contact: Ruchi Sanganeria Corporate
Marketing Tel: +91-22-2584-8000 [email protected] SOURCE SIRO Clinpharm